Free Trial

Inogen (INGN) Competitors

Inogen logo
$8.15 +0.21 (+2.58%)
As of 02:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

INGN vs. EYE, CBLL, BBNX, BFLY, BVS, EMBC, AXGN, SIBN, AVNS, and IRMD

Should you be buying Inogen stock or one of its competitors? The main competitors of Inogen include National Vision (EYE), CeriBell (CBLL), Beta Bionics (BBNX), Butterfly Network (BFLY), Bioventus (BVS), Embecta (EMBC), AxoGen (AXGN), SI-BONE (SIBN), Avanos Medical (AVNS), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry.

Inogen vs.

Inogen (NASDAQ:INGN) and National Vision (NASDAQ:EYE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, community ranking, dividends, valuation, institutional ownership and earnings.

National Vision has a net margin of -0.81% compared to Inogen's net margin of -15.89%. National Vision's return on equity of 3.52% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-15.89% -27.38% -16.77%
National Vision -0.81%3.52%1.39%

Inogen has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500.

Inogen received 135 more outperform votes than National Vision when rated by MarketBeat users. Likewise, 68.97% of users gave Inogen an outperform vote while only 65.13% of users gave National Vision an outperform vote.

CompanyUnderperformOutperform
InogenOutperform Votes
389
68.97%
Underperform Votes
175
31.03%
National VisionOutperform Votes
254
65.13%
Underperform Votes
136
34.87%

National Vision has higher revenue and earnings than Inogen. National Vision is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$335.71M0.56-$102.45M-$1.52-5.23
National Vision$2.18B0.45-$65.90M-$0.20-61.85

In the previous week, Inogen had 8 more articles in the media than National Vision. MarketBeat recorded 26 mentions for Inogen and 18 mentions for National Vision. National Vision's average media sentiment score of 0.78 beat Inogen's score of 0.23 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inogen
2 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral
National Vision
3 Very Positive mention(s)
9 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.9% of Inogen shares are owned by institutional investors. 1.0% of Inogen shares are owned by insiders. Comparatively, 2.3% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Inogen presently has a consensus target price of $7.00, indicating a potential downside of 11.95%. National Vision has a consensus target price of $13.60, indicating a potential upside of 9.94%. Given National Vision's stronger consensus rating and higher probable upside, analysts plainly believe National Vision is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
National Vision
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

National Vision beats Inogen on 12 of the 18 factors compared between the two stocks.

Get Inogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INGN vs. The Competition

MetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$189.35M$9.61B$5.76B$8.47B
Dividend YieldN/A1.39%4.74%3.94%
P/E Ratio-3.5318.5125.1819.05
Price / Sales0.5646.26383.54108.76
Price / CashN/A19.6738.0634.58
Price / Book0.905.697.454.39
Net Income-$102.45M$284.66M$3.19B$246.62M
7 Day Performance-19.78%-3.69%-3.45%-3.46%
1 Month Performance-32.74%-5.88%-3.96%-5.01%
1 Year Performance26.39%-17.44%11.56%6.46%

Inogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INGN
Inogen
3.3882 of 5 stars
$8.16
+2.6%
$7.00
-14.2%
-14.9%$194.09M$335.71M-3.621,030Analyst Forecast
Short Interest ↓
EYE
National Vision
1.6814 of 5 stars
$11.69
-0.1%
$13.40
+14.7%
-46.5%$919.41M$2.18B-58.3713,998Analyst Forecast
News Coverage
Positive News
CBLL
CeriBell
N/A$25.35
+2.7%
$32.60
+28.6%
N/A$903.30M$60.04M0.00N/AEarnings Report
Analyst Forecast
Analyst Revision
News Coverage
BBNX
Beta Bionics
N/A$20.63
+0.3%
$24.83
+20.4%
N/A$884.20MN/A0.00294Analyst Revision
BFLY
Butterfly Network
1.5586 of 5 stars
$4.02
-6.6%
$3.00
-25.3%
+149.7%$857.57M$65.90M-8.75460Earnings Report
News Coverage
Gap Down
BVS
Bioventus
3.2378 of 5 stars
$10.08
+0.6%
$15.00
+48.9%
+97.4%$817.18M$512.34M-16.511,200News Coverage
EMBC
Embecta
4.6152 of 5 stars
$13.77
-2.4%
$23.00
+67.1%
-7.0%$805.16M$1.11B13.852,100Short Interest ↑
AXGN
AxoGen
1.2162 of 5 stars
$17.97
-0.2%
$18.33
+2.0%
+82.1%$793.46M$180.86M-56.34450Analyst Forecast
Analyst Revision
SIBN
SI-BONE
4.2294 of 5 stars
$17.55
-1.6%
$23.00
+31.1%
+0.3%$734.96M$157.04M-19.05350Earnings Report
Analyst Forecast
Analyst Revision
AVNS
Avanos Medical
2.2916 of 5 stars
$15.73
+1.8%
N/A-21.2%$722.58M$681.50M46.243,771Earnings Report
News Coverage
IRMD
Iradimed
4.9328 of 5 stars
$55.14
-1.7%
$72.00
+30.6%
+26.5%$701.67M$73.24M36.91110

Related Companies and Tools


This page (NASDAQ:INGN) was last updated on 2/28/2025 by MarketBeat.com Staff
From Our Partners